June 30, 2020 ST. LOUIS–(BUSINESS WIRE)–CoreLink, LLC, a leading designer and manufacturer of spinal implant systems, today announced the commercial launch and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the F3D-C2 Stand-alone Cervical System. The system is comprised of an additively manufactured spacer with two bone screw anchors secured by a locking …